Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parameters

This publication has 16 references indexed in Scilit:

• Gestoden, an innovative progestogen
  Advances in Contraception, 1987
• A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels
  Contraception, 1985
• Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives
  Contraception, 1984
• Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel
  Contraception, 1984
• Blood prolactin levels: Influence of age, menstrual cycle and oral contraceptives
  Contraception, 1983
• Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel
  Contraception, 1983
• Clinical Pharmacokinetics of Oral Contraceptive Steroids
  Clinical Pharmacokinetics, 1983
• Ethinylestradiol and a New Progestogen (Desogestrel) in a Low-Dose Combination: Effects on Pituitary-Gonadal Function, Serum Sex-Hormone Binding Globulin Capacity, Endometrium and Cervical Mucus
  Published by Wiley ,1982
• Further studies on pituitary and ovarian function in women receiving hormonal contraception
  Contraception, 1981
• Comparison of the Effects of Contraceptive Steroid Formulations Containing Two Doses of Estrogen on Pituitary Function
  Fertility and Sterility, 1978